General Information of Drug (ID: DMTLYDS)

Drug Name
2-hydroxyisoquinoline-1,3(2H,4H)-dione Drug Info
Synonyms
2-hydroxyisoquinoline-1,3(2H,4H)-dione; 6890-08-0; CHEMBL16755; 2-Hydroxy-4H-isoquinoline-1,3-dione; 1,3(2H,4H)-Isoquinolinedione, 2-hydroxy-; 2-hydroxy-1,2,3,4-tetrahydroisoquinoline-1,3-dione; 0N7; AC1LAHYL; N-hydroxyisoquinolinedione, 2; SCHEMBL3358267; BDBM33410; DTXSID70333610; ZINC3626195; 0637AC; AKOS016011468; FCH1154656; ACN-049309; AJ-45130; 2-Hydroxy-1,3(2H,4H)-isoquinolinedione; KB-230940; AX8246098
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
514100
CAS Number
CAS 6890-08-0
TTD Drug ID
DMTLYDS

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
3-hydroxyquinazoline-2,4(1H,3H)-dione DMCXZ9L Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Ribonuclease H (HIV RNH) TT37KAF POL_HV1B1 Inhibitor [1]

References

1 RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. J Med Chem. 2009 Oct 8;52(19):5781-4.